Toleranzia develops protein-based antigen-specific immune tolerogens to cure patients with autoimmune diseases. The drugs have the potential to become the first long-acting or curative therapies that act specifically on the underlying cause of the autoimmune orphan disease for which they are being d... Read more
Org chart
Collapse
No reports!
Teams
Offices
This company has no offices yet
